Status:
COMPLETED
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
University of Florida
Conditions:
Hepatitis C
Eligibility:
All Genders
18+ years
Brief Summary
The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community...
Detailed Description
HCV-TARGET is a longitudinal, observational study that will create a carefully maintained research registry of HCV patients treated with antiviral therapies designed to rapidly inform strategies for b...
Eligibility Criteria
Inclusion
- All adult patients (age 18 or older) being treated with antiviral HCV treatment regimens that contain telaprevir or boceprevir.
Exclusion
- Inability to provide written informed consent.
- Currently participating in another clinical trial of hepatitis C therapeutics. Studies comparing HCV RNA assays are not considered exclusionary.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 9 2022
Estimated Enrollment :
13559 Patients enrolled
Trial Details
Trial ID
NCT01474811
Start Date
November 1 2011
End Date
September 9 2022
Last Update
February 28 2024
Active Locations (60)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic AZ
Phoenix, Arizona, United States, 85054
2
Liver Wellness Center
Little Rock, Arkansas, United States, 72205
3
Scripps
La Jolla, California, United States, 92037
4
UCSD Medical Center
San Diego, California, United States, 92103